Skeletal muscle sodium channelopathies.

Abstract

PURPOSE OF REVIEW:

This is an update on skeletal muscle sodium channelopathies since knowledge in the field have dramatically increased in the past years.

RECENT FINDING:

The relationship between two phenotypes and SCN4A has been confirmed with additional cases that remain extremely rare: severe neonatal episodic laryngospasm mimicking encephalopathy, which should be actively searched for since patients respond well to sodium channel blockers; congenital myasthenic syndromes, which have the particularity to be the first recessive Nav1.4 channelopathy. Deep DNA sequencing suggests the contribution of other ion channels in the clinical expressivity of sodium channelopathies, which may be one of the factors modulating the latter. The increased knowledge of channel molecular structure, the quantity of sodium channel blockers, and the availability of preclinical models would permit a most personalized choice of medication for patients suffering from these debilitating neuromuscular diseases.

SUMMARY:

Advances in the understanding of the molecular structure of voltage-gated sodium channels, as well as availability of preclinical models, would lead to improved medical care of patients suffering from skeletal muscle, as well as other sodium channelopathies.

• Authors: Sophie Nicole, Bertrand Fontaine
• Journal: Current opinion in neurology (Curr Opin Neurol) Vol. 28 Issue 5 Pg. 508-14 (Oct 2015) ISSN: 1473-6551 [Electronic] England
• PMID: 26285000 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Voltage-Gated Sodium Channels

Topics

• Channelopathies (drug therapy, genetics, physiopathology)
• Humans
• Muscle, Skeletal (physiopathology)
• Muscular Diseases (drug therapy, genetics, physiopathology)
• Voltage-Gated Sodium Channels (genetics)